Changes in brain connectivity related to the treatment of depression measured through fMRI: a systematic review

dc.contributor.authorGudayol Ferré, Esteve
dc.contributor.authorPeró, Maribel
dc.contributor.authorGonzález Garrido, Andrés A.
dc.contributor.authorGuàrdia-Olmos, Joan, 1958-
dc.date.accessioned2017-08-31T10:11:45Z
dc.date.available2017-08-31T10:11:45Z
dc.date.issued2015-11-03
dc.date.updated2017-08-31T10:11:45Z
dc.description.abstractDepression is a mental illness that presents alterations in brain connectivity in the Default Mode Network (DMN), the Affective Network (AN) and other cortical-limbic networks, and the Cognitive Control Network (CCN), among others. In recent years the interest in the possible effect of the different antidepressant treatments on functional connectivity has increased substantially. The goal of this paper is to conduct a systematic review of the studies on the relationship between the treatment of depression and brain connectivity. Nineteen studies were found in a systematic review on this topic. In all of them, there was improvement of the clinical symptoms after antidepressant treatment. In 18 out of the 19 studies, clinical improvement was associated to changes in brain connectivity. It seems that both DMN and the connectivity between cortical and limbic structures consistently changes after antidepressant treatment. However, the current evidence does not allow us to assure that the treatment of depression leads to changes in the CCN. In this regard, some papers report a positive correlation between changes in brain connectivity and improvement of depressive symptomatology, particularly when they measure cortical-limbic connectivity, whereas the changes in DMN do not significantly correlate with clinical improvement. Finally, some papers suggest that changes in connectivity after antidepressant treatment might be partly related to the mechanisms of action of the treatment administered. This effect has been observed in two studies with stimulation treatment (one with rTMS and one with ECT), and in two papers that administered three different pharmacological treatments. Our review allows us to make a series of recommendations that might guide future researchers exploring the effect of anti-depression treatments on brain connectivity.
dc.format.extent17 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec655189
dc.identifier.issn1662-5161
dc.identifier.pmid26578927
dc.identifier.urihttps://hdl.handle.net/2445/114827
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3389/fnhum.2015.00582
dc.relation.ispartofFrontiers in Human Neuroscience, 2015, vol. 9, num. 582
dc.relation.urihttps://doi.org/10.3389/fnhum.2015.00582
dc.rightscc-by (c) Gudayol Ferré, Esteve et al., 2015
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Psicologia Social i Psicologia Quantitativa)
dc.subject.classificationDepressió psíquica
dc.subject.classificationAntidepressius
dc.subject.classificationCervell
dc.subject.otherMental depression
dc.subject.otherAntidepressants
dc.subject.otherBrain
dc.titleChanges in brain connectivity related to the treatment of depression measured through fMRI: a systematic review
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
655189.pdf
Mida:
721.45 KB
Format:
Adobe Portable Document Format